{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:29:38Z","timestamp":1787923778671,"version":"build-2784847793"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,31]],"date-time":"2027-07-31T00:00:00Z","timestamp":1816992000000},"content-version":"am","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005339","name":"American Academy of Neurology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"National Institutes of Health Fogarty International Center","doi-asserted-by":"publisher","award":["K01TW011771"],"award-info":[{"award-number":["K01TW011771"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"National Institutes of Health Fogarty International Center","doi-asserted-by":"publisher","award":["D43TW009340"],"award-info":[{"award-number":["D43TW009340"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005331","name":"American Brain Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["PP-1807-32127"],"award-info":[{"award-number":["PP-1807-32127"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.msard.2026.107412","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:36:16Z","timestamp":1785072976000},"page":"107412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["High early mortality and contributing factors in seropositive neuromyelitis optica spectrum disorder at a tertiary hospital in Zambia"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1875-5679","authenticated-orcid":false,"given":"Malya","family":"Sahu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Saylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107412_bib0001","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/jnnp.2007.143529","article-title":"Relapsing neuromyelitis optica: long term history and clinical predictors of death","volume":"80","author":"Cabre","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2026.107412_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102428","article-title":"Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice","volume":"45","author":"Carnero Contentti","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107412_bib0003","article-title":"Diagnostic pathways and barriers in multiple sclerosis in Zambia: a qualitative study","volume":"12","author":"Chomba","year":"2026","journal-title":"Mult. Scler. J. \u2013 Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2026.107412_bib0004","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamaneurol.2023.2974","article-title":"Rapid immunodot AQP4 assay for Neuromyelitis Optica spectrum disorder","volume":"80","author":"Fu","year":"2023","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2026.107412_bib0005","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.msard.2019.05.013","article-title":"Neuromyelitis optica testing and treatment: availability and affordability in 60 countries","volume":"33","author":"Holroyd","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107412_bib0006","doi-asserted-by":"crossref","first-page":"e2089","DOI":"10.1212\/WNL.0000000000006574","article-title":"Racial differences in neuromyelitis optica spectrum disorder","volume":"91","author":"Kim","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107412_bib0007","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/aws109","article-title":"Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan","volume":"135","author":"Kitley","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.msard.2026.107412_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146508","article-title":"Does user fee removal policy provide financial protection from catastrophic health care payments? Evidence from Zambia","volume":"11","author":"Masiye","year":"2016","journal-title":"PLoS. One"},{"key":"10.1016\/j.msard.2026.107412_bib0009","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000468","article-title":"Mortality in neuromyelitis optica is strongly associated with African ancestry","volume":"5","author":"Mealy","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107412_bib0010","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001089","article-title":"Neuromyelitis optica spectrum disorders in Africa: a systematic review","volume":"8","author":"Musubire","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107412_bib0011","article-title":"Predictors of in-hospital and 90-day post-discharge stroke mortality in Lusaka","volume":"437","author":"Nutakki","year":"2022","journal-title":"Zamb., J. Neurol. Sci."},{"key":"10.1016\/j.msard.2026.107412_bib0012","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1212\/WNL.0000000000011153","article-title":"Worldwide incidence and prevalence of neuromyelitis optica: a systematic review","volume":"96","author":"Papp","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107412_bib0013","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209147","article-title":"Mortality of the Danish nationwide AQP4 antibody-seropositive neuromyelitis optica spectrum disorder patient cohort","volume":"102","author":"Papp","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107412_bib0014","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1161\/STROKEAHA.121.037297","article-title":"Inpatient management of acute stroke of unknown type in resource-limited settings","volume":"53","author":"Prust","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.msard.2026.107412_bib0015","doi-asserted-by":"crossref","DOI":"10.1177\/11795735251385319","article-title":"The current State of diagnostics for neuroimmunological disorders in Africa","volume":"17","author":"Sahu","year":"2025","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.msard.2026.107412_bib0016","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/13524585251344832","article-title":"Factors associated with delay to diagnosis of multiple sclerosis in Zambia","volume":"31","author":"Sahu","year":"2025","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107412_bib0017","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-026-26390-9","article-title":"The role of the national health insurance scheme in strengthening delivery of health services among the elderly at district level in Zambia: a qualitative case study","volume":"26","author":"Sakala","year":"2026","journal-title":"BMC. Publ. Health"},{"key":"10.1016\/j.msard.2026.107412_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105365","article-title":"Comorbidity in the multiple sclerosis and neuromyelitis optica spectrum disorders population: findings from an underserved, low income country, Zambia","volume":"81","author":"Tremlett","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107412_bib0019","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1002\/acn3.52178","article-title":"Dried blood spot improves global access to aquaporin-4-IgG testing for neuromyelitis optica","volume":"11","author":"Vorasoot","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.msard.2026.107412_bib0020","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","article-title":"Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays","volume":"78","author":"Waters","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107412_bib0021","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107412_bib0022","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40263-025-01260-x","article-title":"Consensus recommendations for the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD): the MENACTRIMS guidelines","volume":"40","author":"Yamout","year":"2026","journal-title":"CNS. Drugs"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826004475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826004475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:47:45Z","timestamp":1787921265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826004475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":22,"alternative-id":["S2211034826004475"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107412","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High early mortality and contributing factors in seropositive neuromyelitis optica spectrum disorder at a tertiary hospital in Zambia","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107412"}}